Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of CDC7 mRNA | increases expression | 18648102
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of CDC7 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in decreased expression of CDC7 protein | decreases expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of CDC7 mRNA | increases expression | 17530438
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of CDC7 mRNA | increases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CDC7 mRNA | decreases expression | 20382639
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of CDC7 mRNA | decreases expression | 20106945
|
D004317 |
Doxorubicin |
CDC7 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of CDC7 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDC7 mRNA | affects cotreatment|increases expression | 17942748
|
C106014 |
gedunin |
gedunin results in decreased expression of CDC7 mRNA | decreases expression | 17010675
|
D011794 |
Quercetin |
Quercetin results in decreased expression of CDC7 mRNA | decreases expression | 14715546
|
D013974 |
Thyroxine |
Thyroxine results in increased expression of CDC7 mRNA | increases expression | 17403546
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CDC7 mRNA | decreases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDC7 mRNA | affects cotreatment|increases expression | 17942748
|
C496197 |
trans-10,cis-12-conjugated linoleic acid |
trans-10,cis-12-conjugated linoleic acid results in decreased expression of CDC7 mRNA | decreases expression | 17951470
|
C050414 |
tripterine |
tripterine results in decreased expression of CDC7 mRNA | decreases expression | 17010675
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.90 | 14514962 15322242 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.61 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.00 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
10.24 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
10.24 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
10.24 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
10.24 | 14692618 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.65 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.65 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.43 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.58 | 21441931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
4.27 | 17084956 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.12 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.51 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.68 | 15885639 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
5.03 | 15336622 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
4.45 | 19761891 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.08 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
9.06 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.06 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.78 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.76 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.84 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.96 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.96 | 19526202 15692762 15939500 17983394 15136595 17369602 15634643 16115903 18695136 18234424 16264153 15993339 17426702 16096432 15994142 18628466 16935488 18382427 16322301 16826403 16595493 15668708 15567936 11325840 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
1.96 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.96 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.36 | 11589617 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
5.61 | 16962696 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.87 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
8.94 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
8.94 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
8.94 | 11135700 14691202 15073043 15553829 16217749 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
8.94 | 16234567 18059187 17876044 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
8.94 | 19519916 12508355 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
5.00 | 17234771 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.94 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.59 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.59 | 16201981 1485588 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.14 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.72 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.72 | 6189445 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
11.64 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
11.64 | 18670907 18850075 16120746 |
MESH:D006332 |
Cardiomegaly |
|
Thyroxine |
11.64 | 18093424 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.55 | 15792986 17308081 16731534 15476868 16109756 17519947 17351982 17007740 17329180 16612575 16269455 16455267 17131338 17924179 18627295 16242529 15505089 17382496 17928571 17974986 16651473 16278810 16952015 15811867 16364871 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.95 | 16243910 17334414 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
11.25 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.25 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.25 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
13.51 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.51 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
13.51 | 17333356 16105132 17110522 17681005 11677210 16919318 15861022 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.11 | 8697196 15668235 15340226 12621046 16354765 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
2.42 | 19056647 17191121 11134977 16640504 15741050 17148506 19440933 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
3.52 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.52 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
3.52 | 18852136 18095365 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.22 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.48 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.48 | 15322242 20055451 10048152 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.13 | 15213294 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.84 | 18759878 8156756 14531868 12868966 2524372 11906362 8970840 11298694 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.52 | 3621924 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
3.75 | 19496084 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
6.27 | 8291058 18692083 7440962 9653073 9328219 11289319 16192314 6482804 6679447 18648102 1440618 18289764 9022650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.27 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.27 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.18 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.18 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.41 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.96 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.22 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.47 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.05 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.22 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.44 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.44 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
10.44 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
10.44 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
13.24 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.24 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.24 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.08 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.64 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
15.03 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
15.03 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
15.03 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.30 | 16904648 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.44 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
7.44 | 19804834 |
MESH:D005910 |
Glioma |
|
Quercetin |
3.06 | 17643826 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.07 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.55 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.49 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.49 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.50 | 16144979 16879835 16330681 16495754 18674790 14766674 16244371 16244372 16707910 18006777 17888722 17875725 12587719 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.36 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.93 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.55 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.93 | 16120746 15340226 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.43 | 18501091 15147373 17606976 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 16959395 15340226 8697196 18606429 16354765 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
4.06 | 18262572 11834736 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.98 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.64 | 10903974 |
MESH:D006973 |
Hypertension |
|
Quercetin |
8.64 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.64 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.85 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.49 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.50 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.87 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
4.57 | 16624496 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.08 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.36 | 16580747 |
MESH:D007627 |
Keloid |
|
Quercetin |
5.00 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
10.25 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
10.25 | 16775033 15369732 15699352 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
10.25 | 16962696 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.18 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.35 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.35 | 12371664 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.53 | 15070760 |
MESH:D007938 |
Leukemia |
|
Quercetin |
6.53 | 17468513 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.22 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.82 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.36 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.45 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.79 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.14 | 16467208 17050201 20471514 16968895 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.23 | 12679006 9834237 16330433 17712046 17217047 11468182 15622746 12018890 17869043 15336539 19035177 16331271 16823087 15748426 19642359 12712474 16891316 19225113 19075265 15213294 17107899 16112521 16966277 11161223 17649720 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.39 | 16882451 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.21 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.57 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
3.57 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.57 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
14.36 | 9163691 15890375 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
14.36 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
14.36 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
14.36 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.36 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
23.62 | 598648 6587162 1399818 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
23.62 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
23.62 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
23.62 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
23.62 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
23.62 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.37 | 15213294 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
8.61 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
8.61 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
8.61 | 20464547 20869020 17053015 18569708 18520028 20064080 6695378 18816296 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
8.61 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
8.61 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.61 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.48 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.81 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.61 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.05 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.29 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.07 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.53 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.21 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.84 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.12 | 11468182 19417148 15949261 14977855 19549372 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.73 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.16 | 16105982 16882451 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
6.06 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
6.06 | 19595682 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.04 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
3.81 | 19207477 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.00 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.88 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.88 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.18 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
5.18 | 15185748 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.81 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.38 | 18481113 19348381 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.38 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.25 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
7.31 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.31 | 10525206 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.27 | 15555623 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
4.39 | 17929310 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.45 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.08 | 3988306 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
4.25 | 19495926 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.13 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
5.04 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
5.04 | 19005980 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.46 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
5.46 | 16965848 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.72 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.52 | 7296757 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.19 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.53 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.22 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.22 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.19 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
9.19 | 19056647 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.24 | 11896295 11399792 11118676 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.09 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.09 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.09 | 15897917 18437689 16868541 16729912 16888761 15749863 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
2.09 | 14715546 17292933 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.36 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.26 | 17922066 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.39 | 3692021 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.01 | 16767912 17203757 17710206 15625365 18313854 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
10.40 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
10.40 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.84 | 17846226 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
5.61 | 16862918 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.51 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
9.51 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.51 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.61 | 17203757 16767912 15625365 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.00 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.37 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.37 | 20155912 2093021 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.65 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.18 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
12.59 | 12697716 |
MESH:D013959 |
Thyroid Diseases |
|
Thyroxine |
12.59 | 19910387 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.14 | 3712494 6582329 6587162 7505956 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
12.14 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
12.14 | 16010429 17909728 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.01 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
15.93 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
15.93 | 11780464 20435036 12973940 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
15.93 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
15.93 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
15.93 | 16720314 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.33 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.05 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.57 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.26 | 17638931 17678736 17334414 16364871 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |